We are live on ! Find out more
YIH

Y-Intercept (HK) Portfolio holdings

AUM $5.05B
1-Year Est. Return 17.89%
This Fund
S&P 500
This Quarter Est. Return
+13.21%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
AUM
$1.07B
AUM Growth
+$51.2M
Cap. Flow
-$43M
Cap. Flow %
-4.01%
Top 10 Hldgs %
8.18%
Holding
1,747
New
747
Increased
219
Reduced
207
Closed
574

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$12.1M
2
AAPL icon
Apple
AAPL
+$8.41M
3
MSI icon
Motorola Solutions
MSI
+$7.68M
4
JD icon
JD.com
JD
+$7.3M
5
ITW icon
Illinois Tool Works
ITW
+$6.58M

Top Sells

Rank Stock Value
1
BX icon
Blackstone
BX
+$11.4M
2
KVUE icon
Kenvue
KVUE
+$8.1M
3
RTX icon
RTX Corp
RTX
+$7.61M
4
CSCO icon
Cisco
CSCO
+$6.72M
5
ADBE icon
Adobe
ADBE
+$6.58M

Sector Composition

Rank Sector Weight
1 Technology 16.62%
2 Financials 15.83%
3 Consumer Discretionary 13.61%
4 Healthcare 10.98%
5 Industrials 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYRS
1126
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$81.9K 0.01%
+10,512
New +$36K
ESPR
1127
DELISTED
Esperion Therapeutics
ESPR
$81.5K 0.01%
+27,269
New +$35.4K
ALTO icon
1128
Alto Ingredients
ALTO
$344M
$80.6K 0.01%
+30,295
New +$96.5K
REKR icon
1129
Rekor Systems
REKR
$86.4M
$79K 0.01%
+23,731
New +$67.6K
SERA icon
1130
Sera Prognostics
SERA
$78.3M
$78.9K 0.01%
+13,191
New +$38.3K
CTV
1131
DELISTED
Innovid Corp.
CTV
$78.8K 0.01%
+52,560
New +$67K
PBYI icon
1132
Puma Biotechnology
PBYI
$401M
$77.7K 0.01%
+17,946
New +$59.5K
ABOS icon
1133
Acumen Pharmaceuticals
ABOS
$161M
$74.3K 0.01%
+19,348
New +$57.4K
PAYO icon
1134
Payoneer
PAYO
$2.42B
$70.2K 0.01%
+13,483
New +$74.3K
CIA icon
1135
Citizens
CIA
$255M
$67.8K 0.01%
+25,204
New +$77.9K
AUGX
1136
DELISTED
Augmedix, Inc. Common Stock
AUGX
$67.7K 0.01%
+11,572
New +$60.9K
CLOV icon
1137
Clover Health Investments
CLOV
$2.29B
$65.4K 0.01%
+68,709
New +$67.5K
GTHX
1138
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$64.4K 0.01%
+21,121
New +$39.7K
LYRA
1139
DELISTED
LYRA THERAPEUTICS INC
LYRA
$64.3K 0.01%
+246
New +$44.5K
REAL icon
1140
The RealReal
REAL
$1.44B
$64.3K 0.01%
+31,985
New +$62.3K
DIBS icon
1141
1stdibs.com
DIBS
$149M
$63.9K 0.01%
+13,653
New +$57.6K
CBIO
1142
Crescent Biopharma
CBIO
$609M
$62.7K 0.01%
+266
New +$41.4K
DFTX
1143
Definium Therapeutics
DFTX
$5.52B
$61.7K 0.01%
+16,853
New +$50.7K
LNAI
1144
Lunai Bioworks
LNAI
$10.2M
$58.6K 0.01%
+231
New +$63.3K
WRAP icon
1145
Wrap Technologies
WRAP
$95.9M
$58.2K 0.01%
+18,762
New +$42.7K
ORN icon
1146
Orion Group Holdings
ORN
$483M
$58.1K 0.01%
+11,753
New +$57.8K
RPT
1147
Rithm Property Trust
RPT
$95.8M
$57.7K 0.01%
+1,815
New +$55.9K
STXS icon
1148
Stereotaxis
STXS
$126M
$56.9K 0.01%
+32,537
New +$52.6K
UPLD icon
1149
Upland Software
UPLD
$14.7M
$56.8K 0.01%
+1,342
New +$58K
ANIX icon
1150
Anixa Biosciences
ANIX
$118M
$55.8K 0.01%
+14,372
New +$48.5K

Similar funds

Y-Intercept (HK)'s Q4 2023 Portfolio in Review

As of Q4 2023, Y-Intercept (HK) held 1,747 positions worth $1.07B, up 5% from $1.02B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

Y-Intercept (HK) withdrew a net $43M in Q4 2023, closing 574 positions and reducing 207 holdings. Its most notable exit was Blackstone, an estimated $11.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Y-Intercept (HK) opened a new position in Merck worth $12.7M.

  • Y-Intercept (HK)'s largest Q4 2023 buy was Merck: 116,714 shares worth $12.7M.
  • Y-Intercept (HK) added most to Apple in Q4 2023, an estimated $8.41M increase.
  • Y-Intercept (HK)'s biggest Q4 2023 reduction was Kenvue, cutting an estimated $8.1M.
  • Y-Intercept (HK) fully exited Blackstone in Q4 2023, selling an estimated $11.4M.
  • Y-Intercept (HK)'s ten largest holdings make up 8.2% of its $1.07B portfolio in Q4 2023.
  • Y-Intercept (HK) opened 747 new positions and closed 574 in Q4 2023.
  • Y-Intercept (HK)'s portfolio value rose 5% quarter-over-quarter to $1.07B.

Based on Y-Intercept (HK)'s 13F filing for Q4 2023, filed 13 Feb 2024.